EyePoint Pharmaceuticals Announces Completion of Enrollment of Phase 1 DAVIO Clinical Trial of EYP-1901 for the Potential Treatment of Wet AMD

NASDAQ Market News

NEXT STORY
Sean Lavin, MD, Joins Progenity as Vice President, Business Development, Strategy, and Investor Relations
PREV STORY
Intranasal Drug and Vaccine Market 2028 – Insights on Key Trends, COVID-19 Impact, Value Chain Analysis, Strategic Initiatives, and Future Outlook: Adroit Market Research
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

The American Health Council Selects Ruth Dapaah-Afriyie, Pharm.D., B.Pharm., BCACP, CDOE, CVDOE to Industry Board

NEW YORK, June 08, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Ruth ...

author_avatar
NASDAQ Market News

Research: Air Purifiers May Help to Relieve Sleep Apnea Symptoms

author_avatar
NASDAQ Market News

Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging combined data for whole SG016 trial

author_avatar
NASDAQ Market News